{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:34Z","timestamp":1788419854572,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10067-020-05417-5","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T04:02:33Z","timestamp":1601697753000},"page":"1893-1902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role?"],"prefix":"10.1007","volume":"40","author":[{"given":"Enrico","family":"De Lorenzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlando","family":"Natalello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Tanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Magurano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Lucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2248-1058","authenticated-orcid":false,"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"issue":"10","key":"5417_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957\u2013970. https:\/\/doi.org\/10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"issue":"4","key":"5417_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","volume":"41","author":"ME Husni","year":"2015","unstructured":"Husni ME (2015) Comorbidities in psoriatic arthritis. Rheum Dis Clin N Am 41(4):677\u2013698. https:\/\/doi.org\/10.1016\/j.rdc.2015.07.008","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"5417_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","volume":"47","author":"ME Husni","year":"2017","unstructured":"Husni ME, Merola JF, Davin (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351\u2013360. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.010","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5417_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40744-018-0135-1","volume":"6","author":"JF Merola","year":"2019","unstructured":"Merola JF, Shrom D, Eaton J, Dworkin C, Krebsbach C, Shah-Manek B, Birt J (2019) Patient perspective on the burden of skin and joint symptoms of psoriatic arthritis: results of a multi-national patient survey. Rheumatol Ther 6(1):33\u201345. https:\/\/doi.org\/10.1007\/s40744-018-0135-1","journal-title":"Rheumatol Ther"},{"issue":"1","key":"5417_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.reuma.2010.03.003","volume":"7","author":"M Freire","year":"2011","unstructured":"Freire M, Rodr\u00edguez J, M\u00f6ller I, Valc\u00e1rcel A, Tornero C, D\u00edaz G, Armend\u00e1riz Y, Paredes S (2011) Prevalencia de s\u00edntomas de ansiedad y de depresi\u00f3n en pacientes con artritis psori\u00e1sica en consultas de reumatolog\u00eda [Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics]. Reumatol Clin 7(1):20\u201326. Spanish. https:\/\/doi.org\/10.1016\/j.reuma.2010.03.003","journal-title":"Reumatol Clin"},{"issue":"10","key":"5417_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/acr.21725","volume":"64","author":"K Kotsis","year":"2012","unstructured":"Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593\u20131601. https:\/\/doi.org\/10.1002\/acr.21725","journal-title":"Arthritis Care Res"},{"issue":"5","key":"5417_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanct\u00f4t KL, Carvalho AF (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373\u2013387. https:\/\/doi.org\/10.1111\/acps.12698","journal-title":"Acta Psychiatr Scand"},{"key":"5417_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pnpbp.2018.01.003","volume":"83","author":"AS Shariq","year":"2018","unstructured":"Shariq AS, Brietzke E, Rosenblat JD, Barendra V, Pan Z, McIntyre RS (2018) Targeting cytokines in reduction of depressive symptoms: a comprehensive review. Prog Neuro-Psychopharmacol Biol Psychiatry 83:86\u201391. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.01.003","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"9","key":"5417_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2019","unstructured":"Miller AH, Maletic V, Raison CL (2019) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732\u2013741. https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.029","journal-title":"Biol Psychiatry"},{"issue":"1","key":"5417_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27(1):24\u201331. https:\/\/doi.org\/10.1016\/j.it.2005.11.006","journal-title":"Trends Immunol"},{"issue":"10136","key":"5417_CR11","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273\u20132284. https:\/\/doi.org\/10.1016\/S0140-6736(18)30830-4","journal-title":"Lancet"},{"issue":"8","key":"5417_CR12","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5417_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5417_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137\u2013145. https:\/\/doi.org\/10.1002\/art.1780230202","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5417_CR15","first-page":"365","volume":"28","author":"H Nagasawa","year":"2010","unstructured":"Nagasawa H, Kameda H, Sekiguchi N, Amano K, Takeuchi T (2010) Normalisation of physical function by infliximab in patients with RA: factors associated with normal physical function. Clin Exp Rheumatol 28(3):365\u2013372","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"5417_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/rheumatology\/kel074","volume":"45","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Machold KP, Nell VP, Smolen JS (2006) The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey. Rheumatology (Oxford) 45(9):1133\u20131139. https:\/\/doi.org\/10.1093\/rheumatology\/kel074","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5417_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.22456","volume":"67","author":"BR England","year":"2015","unstructured":"England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K (2015) Validation of the rheumatic disease comorbidity index. Arthritis Care Res 67(6):865\u2013872. https:\/\/doi.org\/10.1002\/acr.22456","journal-title":"Arthritis Care Res"},{"issue":"6","key":"5417_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"key":"5417_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.msard.2019.07.030","volume":"35","author":"C De Fino","year":"2019","unstructured":"De Fino C, Lucchini M, Lucchetti D, Nociti V, Losavio FA, Bianco A, Colella F, Ricciardi-Tenore C, Sgambato A, Mirabella M (2019) The predictive value of CSF multiple assay in multiple sclerosis: a single center experience. Mult Scler Relat Disord 35:176\u2013181. https:\/\/doi.org\/10.1016\/j.msard.2019.07.030","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"5417_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/acr.21602","volume":"64","author":"JA Husted","year":"2012","unstructured":"Husted JA, Tom BD, Farewell VT, Gladman DD (2012) Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res 64(5):758\u2013765. https:\/\/doi.org\/10.1002\/acr.21602","journal-title":"Arthritis Care Res"},{"issue":"3","key":"5417_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","volume":"58","author":"BW Penninx","year":"2001","unstructured":"Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58(3):221\u2013227. https:\/\/doi.org\/10.1001\/archpsyc.58.3.221","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"5417_CR22","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wier\u00f8d A, Kalstad S, R\u00f8devand E, Kr\u00f8ll F, Haugeberg G, Kvien TK (2017) Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 76(11):1906\u20131910. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211284","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5417_CR23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","volume":"26","author":"JL Grenard","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF (2011) Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 26(10):1175\u20131182. https:\/\/doi.org\/10.1007\/s11606-011-1704-y","journal-title":"J Gen Intern Med"},{"issue":"4","key":"5417_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/appi.psy.50.4.392","volume":"50","author":"CA Welch","year":"2009","unstructured":"Welch CA, Czerwinski D, Ghimire B, Bertsimas D (2009) Depression and costs of health care. Psychosomatics 50(4):392\u2013401. https:\/\/doi.org\/10.1176\/appi.psy.50.4.392","journal-title":"Psychosomatics"},{"issue":"2","key":"5417_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/rheumatology\/ker216","volume":"51","author":"W Tillett","year":"2012","unstructured":"Tillett W, de-Vries C, McHugh NJ (2012) Work disability in psoriatic arthritis: a systematic review. Rheumatology (Oxford) 51(2):275\u2013283. https:\/\/doi.org\/10.1093\/rheumatology\/ker216","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5417_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.130797","volume":"41","author":"E McDonough","year":"2014","unstructured":"McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887\u2013896. https:\/\/doi.org\/10.3899\/jrheum.130797","journal-title":"J Rheumatol"},{"issue":"6","key":"5417_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/da.22217","volume":"31","author":"R Uher","year":"2014","unstructured":"Uher R, Payne JL, Pavlova B, Perlis RH (2014) Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety 31(6):459\u2013471. https:\/\/doi.org\/10.1002\/da.22217","journal-title":"Depress Anxiety"},{"issue":"5","key":"5417_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3899\/jrheum.100857","volume":"38","author":"A Cauli","year":"2011","unstructured":"Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I, Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fern\u00e0ndez-Sueiro JL, Salvarani C, Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D'Angelo S, Vacca A, VAN Kuijk AW, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS, Mease PJ, GRAPPA 3PPsA Study Group (2011) Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 38(5):898\u2013903. https:\/\/doi.org\/10.3899\/jrheum.100857","journal-title":"J Rheumatol"},{"key":"5417_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","volume":"34","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119\u2013138. https:\/\/doi.org\/10.1146\/annurev-publhealth-031912-114409","journal-title":"Annu Rev Public Health"},{"issue":"Suppl 1","key":"5417_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000316169","volume":"221","author":"R Baran","year":"2010","unstructured":"Baran R (2010) The burden of nail psoriasis: an introduction. Dermatology 221(Suppl 1):1\u20135. https:\/\/doi.org\/10.1159\/000316169","journal-title":"Dermatology"},{"key":"5417_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ynstr.2016.03.003","volume":"4","author":"GE Hodes","year":"2016","unstructured":"Hodes GE, M\u00e9nard C, Russo SJ (2016) Integrating interleukin-6 into depression diagnosis and treatment. Neurobiol Stress 4:15\u201322. https:\/\/doi.org\/10.1016\/j.ynstr.2016.03.003","journal-title":"Neurobiol Stress"},{"key":"5417_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2014.05.006","volume":"41","author":"S Kern","year":"2014","unstructured":"Kern S, Skoog I, B\u00f6rjesson-Hanson A, Blennow K, Zetterberg H, Ostling S, Kern J, Gudmundsson P, Marlow T, Rosengren L, Waern M (2014) Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample. Brain Behav Immun 41:55\u201358. https:\/\/doi.org\/10.1016\/j.bbi.2014.05.006","journal-title":"Brain Behav Immun"},{"key":"5417_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.001","journal-title":"Brain Behav Immun"},{"issue":"3","key":"5417_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno D, Kivim\u00e4ki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG, Ferrie JE (2009) Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39(3):413\u2013423. https:\/\/doi.org\/10.1017\/S0033291708003723","journal-title":"Psychol Med"},{"issue":"10","key":"5417_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB (2014) Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71(10):1121\u20131128. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1332","journal-title":"JAMA Psychiatry"},{"key":"5417_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, Daguanno AW, Woolwine BJ, Goldsmith DR, Baer WM, Wommack EC, Felger JC, Miller AH (2018) Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology 95:43\u201349. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.05.026","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"5417_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hup.717","volume":"20","author":"AD Basterzi","year":"2005","unstructured":"Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, G\u00f6ka E (2005) IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 20(7):473\u2013476. https:\/\/doi.org\/10.1002\/hup.717","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"5417_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1124\/mol.114.096289","volume":"87","author":"JJ Donegan","year":"2015","unstructured":"Donegan JJ, Patton MS, Chavera TS, Berg KA, Morilak DA, Girotti M (2015) Interleukin-6 attenuates serotonin 2a receptor signaling by activating the JAK-STAT pathway. Mol Pharmacol 87(3):492\u2013500. https:\/\/doi.org\/10.1124\/mol.114.096289","journal-title":"Mol Pharmacol"},{"issue":"8","key":"5417_CR39","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1172\/JCI61884","volume":"122","author":"H Kim","year":"2012","unstructured":"Kim H, Chen L, Lim G, Sung B, Wang S, McCabe MF, Rusanescu G, Yang L, Tian Y, Mao J (2012) Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122(8):2940\u20132954. https:\/\/doi.org\/10.1172\/JCI61884","journal-title":"J Clin Invest"},{"issue":"5651","key":"5417_CR40","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1088417","volume":"302","author":"ML Monje","year":"2003","unstructured":"Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651):1760\u20131765. https:\/\/doi.org\/10.1126\/science.1088417","journal-title":"Science"},{"issue":"9","key":"5417_CR41","doi-asserted-by":"publisher","first-page":"e025333","DOI":"10.1136\/bmjopen-2018-025333","volume":"8","author":"GM Khandaker","year":"2018","unstructured":"Khandaker GM, Oltean BP, Kaser M, Dibben CRM, Ramana R, Jadon DR, Dantzer R, Coles AJ, Lewis G, Jones PB (2018) Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 8(9):e025333. https:\/\/doi.org\/10.1136\/bmjopen-2018-025333","journal-title":"BMJ Open"},{"issue":"4","key":"5417_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/cpt.77","volume":"97","author":"JT Henderson","year":"2015","unstructured":"Henderson JT, Piquette-Miller M (2015) Blood-brain barrier: an impediment to neuropharmaceuticals. Clin Pharmacol Ther 97(4):308\u2013313. https:\/\/doi.org\/10.1002\/cpt.77","journal-title":"Clin Pharmacol Ther"},{"key":"5417_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","volume":"44","author":"WA Banks","year":"2015","unstructured":"Banks WA (2015) The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun 44:1\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2014.08.007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5417_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356. https:\/\/doi.org\/10.1038\/nrn2297","journal-title":"Nat Rev Neurosci"},{"key":"5417_CR45","doi-asserted-by":"publisher","first-page":"713618","DOI":"10.1155\/2012\/713618","volume":"2012","author":"A Ogata","year":"2012","unstructured":"Ogata A, Kumanogoh A, Tanaka T (2012) Pathological role of interleukin-6 in psoriatic arthritis. Arthritis 2012:713618. https:\/\/doi.org\/10.1155\/2012\/713618","journal-title":"Arthritis"},{"issue":"6","key":"5417_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","volume":"13","author":"M Narazaki","year":"2017","unstructured":"Narazaki M, Tanaka T, Kishimoto T (2017) The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol 13(6):535\u2013551. https:\/\/doi.org\/10.1080\/1744666X.2017.1295850","journal-title":"Expert Rev Clin Immunol"},{"key":"5417_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbi.2018.05.012","volume":"73","author":"YH Cheon","year":"2018","unstructured":"Cheon YH, Lee SG, Kim M, Kim HO, Sun Suh Y, Park KS, Kim RB, Yang HS, Kim JM, Son CN, Kyoung Park E, Kim SH, Lee SI (2018) The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis. Brain Behav Immun 73:274\u2013281. https:\/\/doi.org\/10.1016\/j.bbi.2018.05.012","journal-title":"Brain Behav Immun"},{"issue":"11","key":"5417_CR48","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10067-013-2309-0","volume":"32","author":"N Nishina","year":"2013","unstructured":"Nishina N, Kaneko Y, Kameda H, Kuwana M, Takeuchi T (2013) Reduction of plasma IL-6 but not TNF-\u03b1 by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression. Clin Rheumatol 32(11):1661\u20131666. https:\/\/doi.org\/10.1007\/s10067-013-2309-0","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05417-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05417-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05417-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T21:00:40Z","timestamp":1633381240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05417-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5417"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05417-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The study complies with the Declaration of Helsinki, the locally appointed ethics committee has approved the research protocol, and informed consent has been obtained from the enrolled subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}